Stock listing
A2APCZ Stock Price, News, Filings & Events — Madrigal Pharmaceuticals, Inc.
Selected listing: A2APCZ · LS · EUR · DE
This page tracks Madrigal Pharmaceuticals, Inc.'s A2APCZ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2APCZ:LS. A2APCZ:LS is the stock-level entry point for investors researching Madrigal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2APCZ:LS
- Asset type
- Stock
- Market cap
- $12.33B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Madrigal Pharmaceuticals, Inc. A2APCZ:LS stock context
This page tracks Madrigal Pharmaceuticals, Inc.'s A2APCZ:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2APCZ:LS. A2APCZ:LS is the stock-level entry point for investors researching Madrigal Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Madrigal Pharmaceuticals, Inc.
Madrigal Appoints John C. Reed, M.D., Ph.D., to its Board of Directors
August 12, 2026
Madrigal Pharmaceuticals Reports Second-Quarter 2026 Financial Results and Provides Corporate Updates
July 30, 2026
Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
July 16, 2026
Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
July 13, 2026
Madrigal Pharmaceuticals to Participate in the 47th Annual Global Goldman Sachs Health Care Conference 2026
June 3, 2026
Madrigal Pharmaceuticals, Inc. earnings calls
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2026 Earnings Call
July 30, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q4 2025 Earnings Call
February 19, 2026 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q2 2025 Earnings Call
August 5, 2025 · Replay with transcript and chapters
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Research Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for A2APCZ:LS.
Madrigal Pharmaceuticals, Inc. company profile
View the public company page for Madrigal Pharmaceuticals, Inc. on 6ix.
Madrigal Pharmaceuticals, Inc. news
Read company news and market updates connected to Madrigal Pharmaceuticals, Inc..
Madrigal Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Madrigal Pharmaceuticals, Inc..
Alternate listings
MDGL:NASDAQ
US · USD
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
A2APCZ:LSX
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:GETTEX
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:TRADEGATE
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
0JXI:LSE
GB · USD
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
MDGL:BOATS
US · USD
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
1MDGL:MIL
IT · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:FWB
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:BX
CH · CHF
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:DUS
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:HAM
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.
YDO1:MUN
DE · EUR
Alternate listing for Madrigal Pharmaceuticals, Inc.; the primary context on this page is A2APCZ:LS.